The invention provides a material having a structure including three or more anthracene structures per molecule as a photosensitive unit. That structure allows the material to remain in a liquid state at room temperature due to its reduced crystallinity. After coated on an application member in a liquid state, it is irradiated with light from outside so that it can be cured by way of photocrosslinking, and when heated, it returns back to the original state as the linkage is cleaved. By use of this material it is possible to form a reversibly detachable layer that serves as an adhesive layer at an interface to an application member and a coating layer at the surface of the application member.

The invention provides a material having a structure including three or more anthracene structures per molecule as a photosensitive unit. That structure allows the material to remain in a liquid state at room temperature due to its reduced crystallinity. After coated on an application member in a liquid state, it is irradiated with light from outside so that it can be cured by way of photocrosslinking, and when heated, it returns back to the original state as the linkage is cleaved. By use of this material it is possible to form a reversibly detachable layer that serves as an adhesive layer at an interface to an application member and a coating layer at the surface of the application member.

A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I): ##STR00001##

A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I): ##STR00001##

The present invention is related to substituted butanol derivatives of the formula: ##STR00001##
wherein R is an unsubstituted or substituted C.sub.1-6 straight chain alkyl, an unsubstituted or substituted C.sub.3-6 branched chain alkyl, an unsubstituted or substituted C.sub.3-6 straight chain alkenyl, an unsubstituted or substituted C.sub.3-6 branched chain alkenyl, an unsubstituted or substituted C.sub.3-6 cycloalkyl, an unsubstituted or substituted C.sub.1-6 alkoxy, nitrile, halo, amino, an unsubstituted or substituted C.sub.1-6 alkylamino, an unsubstituted or substituted C.sub.1-6 dialkylamino, carboxy-C.sub.1-6 alkylamino, carboxy-C.sub.1-6 dialkylamino, an unsubstituted or substituted acetoxy, carboxy, an unsubstituted or substituted carboxyethyl, an unsubstituted or substituted C.sub.1-6 alkylcarbonyl, an unsubstituted or substituted C.sub.1-6 alkylcarboxy, an unsubstituted or substituted C.sub.1-6 alkylthio, an unsubstituted or substituted C.sub.1-6 alkyloxy, carboxamido, an unsubstituted or substituted C.sub.1-6 alkylcarboxamido or an unsubstituted or substituted C.sub.1-6 dialkylcarboxamido. Such compounds are useful in flavor or flavor compositions.

The present invention is related to substituted butanol derivatives of the formula: ##STR00001##
wherein R is an unsubstituted or substituted C.sub.1-6 straight chain alkyl, an unsubstituted or substituted C.sub.3-6 branched chain alkyl, an unsubstituted or substituted C.sub.3-6 straight chain alkenyl, an unsubstituted or substituted C.sub.3-6 branched chain alkenyl, an unsubstituted or substituted C.sub.3-6 cycloalkyl, an unsubstituted or substituted C.sub.1-6 alkoxy, nitrile, halo, amino, an unsubstituted or substituted C.sub.1-6 alkylamino, an unsubstituted or substituted C.sub.1-6 dialkylamino, carboxy-C.sub.1-6 alkylamino, carboxy-C.sub.1-6 dialkylamino, an unsubstituted or substituted acetoxy, carboxy, an unsubstituted or substituted carboxyethyl, an unsubstituted or substituted C.sub.1-6 alkylcarbonyl, an unsubstituted or substituted C.sub.1-6 alkylcarboxy, an unsubstituted or substituted C.sub.1-6 alkylthio, an unsubstituted or substituted C.sub.1-6 alkyloxy, carboxamido, an unsubstituted or substituted C.sub.1-6 alkylcarboxamido or an unsubstituted or substituted C.sub.1-6 dialkylcarboxamido. Such compounds are useful in flavor or flavor compositions.

The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

The present invention relates to a plasticizer composition and a preparation method therefor and, more specifically, to a plasticizer composition, which contains an anhydrosugar alcohol monoester, an anhydrosugar alcohol diester, and a sugar alcohol ester at a specific content ratio and has improved plasticity and excellent storage stability, and to a preparation method therefor.

The present invention relates to a plasticizer composition and a preparation method therefor and, more specifically, to a plasticizer composition, which contains an anhydrosugar alcohol monoester, an anhydrosugar alcohol diester, and a sugar alcohol ester at a specific content ratio and has improved plasticity and excellent storage stability, and to a preparation method therefor.